Befovacimab (Anti-TFPI)
A2779
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameBefovacimab (Anti-TFPI)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionBefovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitors (TFPI) with the potential to be used in haemophilia A/B research. MW: 143.24 kD.
- Storage Instruction-20°C
- UNSPSC12352203